Anna Kanerva

机构：University of Helsinki, Helsinki University Hospital · ORCID：0000-0003-3355-7393

发表论文 322 篇 · 总被引 6882 次 · h-index 46

代表论文

Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors (2024 · Journal of Experimental & Clinical Cancer Research · 被引 24)
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer (2023 · Cancer Gene Therapy · 被引 12)
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine (2023 · Cancer Gene Therapy · 被引 12)
Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models (2025 · Cancer Immunology Immunotherapy · 被引 6)
PPP2R1A mutation status as a predictive and prognostic factor in molecularly characterized endometrial carcinoma: a cohort study (2025 · International Journal of Gynecological Cancer · 被引 6)
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes (2025 · Cancer Gene Therapy · 被引 5)